Vantage Nutrition acquires AquaCap from Nestlé Health Science
A leading contract manufacturer of liquid-filled capsules, AquaCap’s novel liquid technology enables liquid filling of hard gelatin and vegetarian capsules.
Photo © Shutterstock.com/Jirus Malawong
Vantage Nutrition, an ACG Group company, has acquired the AquaCap (Philadelphia, PA) from Nestlé Health Science. A leading contract manufacturer of liquid-filled capsules, AquaCap’s novel liquid technology enables liquid filling of hard gelatin and vegetarian capsules. Vantage Nutrition already has a reputation as an innovator of two-piece liquid-fill capsule solutions, making the acquisition highly complementary.
“Although ACG has been established in North America for the last 20 years, this marks our first acquisition in the territory and is a key next step in our global expansion strategy,” said Karan Signh, managing director of ACG, in a press release. “With this increase in our footprint and manufacturing capability, coupled with Vantage’s innovative technologies and 360-degree service offering, we aim to provide the most advanced multiphase liquid-fill solutions for customers across the region.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
